Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Comparative Bioavailability Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults

NCT05152901 is registered in ClinicalTrials.gov with De Motu Cordis as lead sponsor.

NCT NCT05152901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05152901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Comparative Bioavailability Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults
Lead sponsor
De Motu Cordis
Phase
Phase 1
Overall status
Completed
Start date
January 6, 2022
Completion date
June 6, 2022
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaphylactic reaction